The Pet Food Nutraceuticals Market was worth USD 4.77 billion in 2021 and estimated to be growing at a CAGR of 4.12%, to reach USD 5.84 billion by 2026.
The health-conscious user perceives nutrition enabled foods as a substitute for healthcare expenses, thereby driving the growth of the global nutraceutical market.
The pet food nutraceuticals market is characterized as dietary supplements, functional or medicinal food products that supply a source of a standard vital nutrient, like calcium or vitamin A. They are meant to function as supplements and guarantee the nutritional wholeness of the pet diet.
The growth of the Pet Food Nutraceuticals market is majorly driven by factors such as an increasing number of people adopting pets, user attitudinal transformation towards pets with curiosity on their nutrition and health, and rapid urbanization. However, factors such as different regulatory bodies and lack of raw materials are restraining the growth of the market. Another major challenge for the market is the lack of recognition of pet food in under-developed countries due to low incomes.
Ingredient Type
Omega 3 fatty acids
Under this segment, Immune system leads the global market, followed by Food Allergies and Pain Relief.
The market is geographically divided into:
North America and Europe are the main users accounting for around 60% of the entire market. U.S. is the major market and is also projected to be the fastest-growing country in North America. The Asia Pacific market has the highest CAGR due to factors such as increasing urbanization and growing disposable incomes, thereby leading to increased adoption of pets.
Major Key Players:
The major players in this market are focusing in the areas of Digestive health, weight management and beauty (Skin and Coat). The major companies dominating the global Pet Food Nutraceuticals market are Diana group, BASF SE, Chr. Hansen A/S, Kemin Industries Inc., Nutraceutical International LLC, and Royal DSM N.V.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Ingredient Type
5.1.1 Omega 3 fatty acids
5.1.2 Proteins and Peptides
5.1.3 Milk Bio actives
5.1.4 Probiotics
5.1.5 Dietary Fibre
5.1.6 Others
5.2 By Function type
5.2.1 Nutrition/Therapeutic
5.2.2 Supplements
5.3 By Pet Type
5.3.1 Cats
5.3.2 Fish
5.3.3 Dogs
5.3.4 Bird
5.3.5 Others
5.4 By Application Type
5.4.1 Weight Management
5.4.2 Immune system
5.4.3 Food Allergies
5.4.4 Pain Relief
5.4.5 Digestive health
5.4.6 Skin and Coat
5.4.7 Eye care
5.4.8 Others
6. Geographical Analysis
6.1 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.2 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.3 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 South Korea
6.3.6 Australia
6.4 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.4.5 Rest of Latin America
6.5 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Diana group
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 BASF SE
8.3 Chr. Hansen A/S
8.4 Kemin Industries Inc.
8.5 Nutraceutical International LLC
8.6 Royal DSM N.V
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
